Decoy Therapeutics Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Decoy Therapeutics Inc. (DCOY) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $367 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-07.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2018-03-07
- Decoy Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2017 was $367.00, a 98.41% decline from fiscal 2016.
- Decoy Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2016 was $23.04K.
- Decoy Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2015 was -$24.65K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|
| 2017-12-31 | $367.00 10-K · filed 2018-03-07 |
| 2016-12-31 | $23.04K 10-K · filed 2018-03-07 |
| 2015-12-31 | -$24.65K 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |